Radiation dose and breast cancer risk in the childhood cancer survivor study. - Wikidata - awgldk - TriplyDB

Radiation dose and breast cancer risk in the childhood cancer survivor study.

Radiation dose and breast cancer risk in the childhood cancer survivor study.

http://www.wikidata.org/entity/Q37324982

about

Breast cancer in female survivors of childhood, adolescent or young adult cancer after radiotherapy involving the chest for their primary malignancy Radiation acts on the microenvironment to affect breast carcinogenesis by distinct mechanisms that decrease cancer latency and affect tumor type Second malignant neoplasms and cardiovascular disease following radiotherapy.Second solid cancers after radiation therapy: a systematic review of the epidemiologic studies of the radiation dose-response relationship Solid tumor second primary neoplasms: who is at risk, what can we do?Pediatric Exposures to Ionizing Radiation: Carcinogenic Considerations Collaborative Research in Childhood Cancer Survivorship: The Current Landscape Cancer mortality following radiotherapy for benign gynecologic disorders Therapeutic radiation and the potential risk of second malignancies.Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer.Dosimetric advantages of a "butterfly" technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin's lymphoma Breast cancer risk after radiotherapy for heritable and non-heritable retinoblastoma: a US-UK study.A French national breast and thyroid cancer screening programme for survivors of childhood, adolescent and young adult (CAYA) cancers - DeNaCaPST programme The value of FATS expression in predicting sensitivity to radiotherapy in breast cancer Breast cancer after chest radiation therapy for childhood cancer.Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study Breast cancer risk 55+ years after irradiation for an enlarged thymus and its implications for early childhood medical irradiation today.Long-term survivors of childhood Ewing sarcoma: report from the childhood cancer survivor study.Comparison of therapeutic dosimetric data from passively scattered proton and photon craniospinal irradiations for medulloblastoma Methodological extensions of meta-analysis with excess relative risk estimates: application to risk of second malignant neoplasms among childhood cancer survivors treated with radiotherapy.Childhood and adolescent cancer statistics, 2014.Do DNA Double-Strand Breaks Drive Aging?Second malignancies in patients with neuroblastoma: the effects of risk-based therapy.Breast cancer in female survivors of Wilms tumor: a report from the national Wilms tumor late effects study Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein Current knowledge and future research directions in treatment-related second primary malignancies.Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.Assessment of uncertainties in radiation-induced cancer risk predictions at clinically relevant doses.Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study.Long-term effects of radiation exposure among adult survivors of childhood cancer: results from the childhood cancer survivor study.Dose-response relationship for breast cancer induction at radiotherapy dose Genetic variation as a modifier of association between therapeutic exposure and subsequent malignant neoplasms in cancer survivors.Genetic Background Modulates lncRNA-Coordinated Tissue Response to Low Dose Ionizing Radiation.Characterization of genomic alterations in radiation-associated breast cancer among childhood cancer survivors, using comparative genomic hybridization (CGH) arrays.Impact of Cancer Therapy-Related Exposures on Late Mortality in Childhood Cancer Survivors.Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics.Risk factors associated with secondary sarcomas in childhood cancer survivors: a report from the childhood cancer survivor study.Risk of Late Mortality and Second Malignant Neoplasms among 5-Year Survivors of Young Adult Cancer: A Report of the Childhood, Adolescent, and Young Adult Cancer Survivors Research Program.Health care utilization, lifestyle, and emotional factors and mammography practices in the Childhood Cancer Survivor Study.Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study.

P2860

Q24201177-10BE9418-E908-4FB3-AE50-A142F9772823 Q24620175-1FF99A68-A82F-4A1A-A5DF-8236733C2906 Q26864522-375B8640-DAE1-42E4-A08A-6C6202CD30FC Q26996120-89BB47E5-593F-4E3F-8648-66EF57286CE5 Q27026266-9B90A49A-2774-4586-8563-52816AD027D3 Q28070290-3AC0D118-BBAC-4107-AE67-B93E9D33D38B Q28081135-9C2E1700-59CA-4034-8172-02CB30C18900 Q28389787-6743D077-2FA3-4975-B19E-BCB86C7A42E6 Q30251822-19FA28F1-73F6-42BC-91F9-DA19BF8E73D0 Q33549627-ECD98BFD-A1EE-4A3A-9473-E41D003D4FA6 Q33579820-AFA8FAB6-9602-481F-9B06-A7C3AAA31B71 Q33613662-695B6364-C74A-4FD6-A676-304E29A7E428 Q33667638-DFC2E2A2-ECEA-4A11-9303-8B49053E224E Q33888843-217F4BAE-F237-49D7-8BCE-46BA89867CC2 Q33910979-7811F280-0616-4EC8-92E9-5996E138FEA1 Q34008980-FD8A6C98-F4A6-40E9-85E2-76546F73DED5 Q34128029-6BC45484-23E1-492D-A4F8-BE25D83A2EFC Q34169663-C80FE986-F990-4618-9171-3F7E598533BE Q34350198-D2174055-3BB9-4503-B346-3F7607C61B12 Q34366619-08F7201C-7DDE-4A2F-9013-E641782CDAA0 Q34401667-222D506C-7332-4BE8-B6EE-864714A14A97 Q34539270-121A5EE4-BD1D-4056-B594-0FC8CF68EAF2 Q34543549-47A40118-E06D-415D-A4DF-9C3D26EB7CF2 Q34550672-7C5406AC-5741-4C34-BE0C-683D3EE5EC61 Q34583585-4BB157D4-D7CE-4696-B6B9-59A3631FDD1D Q34604460-2134AF35-1130-4FD7-BC6D-E8562E7B0685 Q34639851-E970B9E5-D55F-4F86-B2FF-CB8D285DBAE7 Q34744993-C6E349EF-60CE-45ED-8064-F0CDDF3CE4FA Q34822439-78D345FC-3554-4BDB-A80D-9748A3A2B790 Q34822530-D8C5B304-68AB-44ED-96E5-C07C88444AA5 Q35081212-F8AF3FCC-E1F4-41F0-9241-238262D32621 Q35117677-29D816F1-05C3-41E9-B47C-500F1B512D58 Q35158537-1DCB92E3-1F36-428B-8A83-FBD0497AF7A8 Q35170898-E36814E9-680D-4F22-8DA3-F9196AAD9A65 Q35761588-34649BAD-6DCD-43F8-A28E-D2455097D298 Q36057728-69196BF1-FD00-4A69-A19A-6B87A26F5DA0 Q36176997-636FC78C-A564-45BD-9D4A-0271D5451F09 Q36248367-A923200D-1715-48ED-85D1-014E37106668 Q36248877-AA858FCC-6641-4D55-AEEC-968B90FFA441 Q36914353-D2E12882-2BE2-4D3B-A26C-38E7D0A8A78C

P2860

Radiation dose and breast cancer risk in the childhood cancer survivor study.

http://www.wikidata.org/entity/Q37324982

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Radiation dose and breast cancer risk in the childhood cancer survivor study.

@en

Radiation dose and breast cancer risk in the childhood cancer survivor study.

@nl

type

label

Radiation dose and breast cancer risk in the childhood cancer survivor study.

@en

Radiation dose and breast cancer risk in the childhood cancer survivor study.

@nl

prefLabel

Radiation dose and breast cancer risk in the childhood cancer survivor study.

@en

Radiation dose and breast cancer risk in the childhood cancer survivor study.

@nl

P1433

Q37324982-448E8557-389E-475E-8998-411DDA5EBF6D

P1476

Q37324982-220991FE-8FAB-45B5-8366-3DE2F14340BE

P2093

Q37324982-21A7856A-17AB-4108-8EC4-8E9CB53904BE

Q37324982-328EAD89-A420-46FA-8131-B81E85F0EC52

Q37324982-428EAFC6-1D72-4F83-84F9-E3092B94E4C6

Q37324982-6BF4819C-802E-49EB-8B4D-CA349B8E6EDF

Q37324982-90D05636-EB35-4FB5-BBD0-4EB9AB856A7A

Q37324982-972E4D4E-36FC-41CE-8305-8172D0C5E47E

Q37324982-9FF0A38C-3879-46B5-8DCF-A5FAFA79BD0C

Q37324982-B7D94603-ED7D-43ED-86D1-5E8F02245B0D

Q37324982-BCE42FAB-4411-4BD9-8E38-075A65D8B305

Q37324982-CD1716F8-54AB-4B39-BB38-4D7B39250836

P2860

Q37324982-12821F0F-BD56-4E79-92BD-B5234AAFC42F

Q37324982-13F59B45-91A6-4705-9576-AE75CC433166

Q37324982-14C3F991-B8EB-46BA-A480-F818A1E67DD6

Q37324982-2A4994E8-4723-4964-82B2-91B8EFFF178F

Q37324982-3A620CBB-14BB-4BEA-88AA-8D2C58126659

Q37324982-4EF93719-706B-4485-B974-F8A5FE0FCBDD

Q37324982-57733207-44AF-4D13-87F1-BDB8D5A1131F

Q37324982-5F0C2163-B1B7-4B1F-9832-1FE5F41FA1D2

Q37324982-8FCB2247-E584-406C-830D-8D641C889E31

Q37324982-9F15E695-9AA2-4299-A3AC-3209AAFBC150

P304

Q37324982-C6E735AA-AA92-436D-9CC7-52809E3336A8

P31

Q37324982-06C1AB9F-B1B6-4F11-BF80-02CB8BB5550E

P356

Q37324982-9122DEDC-62A4-477A-ACBE-68D67F6D8894

P407

Q37324982-099C5623-399D-4F8B-8211-FDC4216A961A

P433

Q37324982-7AA59AE6-8F54-4303-883C-DB39AF09995A

P478

Q37324982-64338EA5-FEE0-4CE8-9F71-C7B20B131595

P577

Q37324982-D881AC63-31B8-4960-B02A-094B8876DF3A

P698

Q37324982-23DC2E06-791F-42C6-972E-3E9703746604

P932

Q37324982-943075A3-2CD9-43A1-ADBA-8128595A74C1

P356

JCO.2008.20.7738

P1433

Journal of Clinical Oncology

P1476

Radiation dose and breast cancer risk in the childhood cancer survivor study.

@en

P2093

Ann C Mertens

http://www.w3.org/2001/XMLSchema#string

Anna T Meadows

http://www.w3.org/2001/XMLSchema#string

John A Whitton

http://www.w3.org/2001/XMLSchema#string

Joseph P Neglia

http://www.w3.org/2001/XMLSchema#string

Leslie L Robison

http://www.w3.org/2001/XMLSchema#string

Lisa Diller

http://www.w3.org/2001/XMLSchema#string

Lisa Kenney

http://www.w3.org/2001/XMLSchema#string

Marilyn Stovall

http://www.w3.org/2001/XMLSchema#string

Peter D Inskip

http://www.w3.org/2001/XMLSchema#string

Sarah S Donaldson

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood

Maintenance of ovarian function and risk of premature menopause related to cancer treatment.

Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party.

Dose reconstruction for therapeutic and diagnostic radiation exposures: use in epidemiological studies.

Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.

Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment.

Pediatric radiotherapy. An overview.

Breast cancer and other second neoplasms after childhood Hodgkin's disease.

High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group.

Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease.

P304

3901-3907

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2008.20.7738

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19620485

http://www.w3.org/2001/XMLSchema#string

P932

2734395

http://www.w3.org/2001/XMLSchema#string